IL115177A0 - Phosphorus-32 labeling of antibodies for cancer therapy - Google Patents

Phosphorus-32 labeling of antibodies for cancer therapy

Info

Publication number
IL115177A0
IL115177A0 IL11517795A IL11517795A IL115177A0 IL 115177 A0 IL115177 A0 IL 115177A0 IL 11517795 A IL11517795 A IL 11517795A IL 11517795 A IL11517795 A IL 11517795A IL 115177 A0 IL115177 A0 IL 115177A0
Authority
IL
Israel
Prior art keywords
labeling
antibodies
phosphorus
cancer therapy
cancer
Prior art date
Application number
IL11517795A
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of IL115177A0 publication Critical patent/IL115177A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5412IL-6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13Labelling of peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
IL11517795A 1994-09-16 1995-09-05 Phosphorus-32 labeling of antibodies for cancer therapy IL115177A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30810394A 1994-09-16 1994-09-16

Publications (1)

Publication Number Publication Date
IL115177A0 true IL115177A0 (en) 1995-12-31

Family

ID=23192557

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11517795A IL115177A0 (en) 1994-09-16 1995-09-05 Phosphorus-32 labeling of antibodies for cancer therapy

Country Status (6)

Country Link
EP (1) EP0783516A4 (en)
JP (1) JPH10511263A (en)
AU (1) AU3548895A (en)
CA (1) CA2200088A1 (en)
IL (1) IL115177A0 (en)
WO (1) WO1996008506A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874540A (en) * 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
CA2495825C (en) * 2002-08-19 2015-03-17 Merck Patent Gesellschaft Mit Beschraenkter Haftung Variants of the major allergen phl p 1 from timothy grass
CA2501616C (en) 2002-10-08 2015-05-12 Immunomedics, Inc. Antibody therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077195A (en) * 1985-03-01 1991-12-31 Board Of Reagents, The University Of Texas System Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
US4923802A (en) * 1985-06-13 1990-05-08 Immunex Corporation Peptide substrates for the detection, characterization and purification of protein kinase C
GB2186579B (en) * 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins
GB8906708D0 (en) * 1989-03-23 1989-05-10 Foxwell Brian M J Improvements relating to the radiolabelling of proteins
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
ES2204891T3 (en) * 1991-04-19 2004-05-01 The Board Of Regents Of The University Of Washington DNA CODIFYING PHOSPHODESTERASES OF MAMMALS.
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins
US5366889A (en) * 1992-11-30 1994-11-22 The General Hospital Corporation DNA encoding a protein-coupled receptor kinase

Also Published As

Publication number Publication date
AU3548895A (en) 1996-03-29
EP0783516A1 (en) 1997-07-16
WO1996008506A1 (en) 1996-03-21
JPH10511263A (en) 1998-11-04
CA2200088A1 (en) 1996-03-21
EP0783516A4 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
ZA9811314B (en) Novel compounds and methods for synthesis and therapy
IL234696A (en) Anti- erbb2 antibodies for preparation of medicaments for treatment of cancer
IL131560A0 (en) Compounds for immunotherapy of prostate cancer and methods for their use
GB2318734B (en) Methods of preventing breast cancer
HK1120494A1 (en) Novel compounds and methods for synthesis and therapy
GB9410320D0 (en) Novel therapeutic method
GB9509572D0 (en) Cancer therapy
HUP9900011A3 (en) Use of protein gax for treating cancer
IL115177A0 (en) Phosphorus-32 labeling of antibodies for cancer therapy
ZA953560B (en) Tumor localising photosensitising compounds
GB9703633D0 (en) Cancer therapy
GB2303066A9 (en) Magnetic therapy system
GB2312375B (en) Agents for treatment of cancer
ZA988451B (en) Novel compounds and methods for synthesis and therapy
GB9504415D0 (en) Novel treatments for cancer
GB9624800D0 (en) Methods of preventing breast cancer
IL120901A0 (en) Cancer therapy
GB9701876D0 (en) Cancer therapy
ZA981585B (en) Compounds for immunotherapy of prostate cancer and methods for their use
GB9416932D0 (en) Tumour specific photeoglycan
GB9417061D0 (en) Novel method of therapy
AU2003204079A1 (en) Novel compounds and methods for synthesis and therapy
GB9217270D0 (en) Tumour therapy
ZA95941B (en) Liphophilic carrier preparations
GB9523801D0 (en) Therapeutic compounds